Elastrin Therapeutics Inc. Closes Seed Funding Round with Kizoo Technology Capital

Elastrin – a biotechnology startup leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again is the latest addition to the growing portfolio of Kizoo Technology Capital, a rejuvenation biotech investor focused on reversing age-related damage on a cellular and molecular level. Elastrin’s lead asset is a nanoparticle conjugated with a novel monoclonal antibody for the treatment of heart valve and vascular calcification.